NHIQ — Nanthealth Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $1.37m
- $319.76m
- $67.00m
Annual cashflow statement for Nanthealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -192 | -62.8 | -56.4 | -58.5 | -67.8 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 138 | 26.3 | 20.6 | 7.69 | 7.98 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 5.93 | 5.86 | 2.19 | 7.51 | 12.2 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -29.6 | -8.77 | -16.9 | -27.7 | -32.3 |
Capital Expenditures | -10.5 | -4.59 | -5.67 | -5.08 | -6.47 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.068 | 0.3 | 40.9 | -0.556 | 0 |
Acquisition of Business | |||||
Sale of Business | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -10.5 | -4.29 | 35.3 | -5.64 | -6.47 |
Financing Cash Flow Items | -2.07 | -0.27 | -0.739 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -2.16 | -0.032 | -0.555 | 40.6 | 10.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -42.6 | -13.1 | 17.8 | 7.24 | -27.8 |